ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Luye Pharma (2186.HK)
Luye Pharma share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$1.60▼ -0.62%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Luye Pharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Luye Pharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Luye Pharma a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$1.48 and HK$1.71; in 9 out of 10, between HK$1.30 and HK$1.96. Estimated annual volatility is 42%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$6.8B
- Market cap (USD)
- $868M
- P/E ratio
- 24.4
- 52-week high
- HK$3.27
- 52-week low
- HK$1.55
- Revenue (12 months)
- CN¥6.1B
- Gross margin
- 63.7%
- Operating margin
- 14.8%
- Net margin
- 11.4%
- Beta
- 0.87
What this means
ATLAS does not publish a fair value for 2186.HK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 2186.HK has traded between HK$1.55 and HK$3.27. Today it is 51.2% below that high and 3% above its low.
On the business: net margin is 11.4%; it trades at 24.4 times earnings.
Its beta is 0.87: it moves roughly in line with the market.
About the company
Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally.
Want to see everything about Luye Pharma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Luye Pharma do?
Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally.
What is the chance 2186.HK goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, 2186.HK ends the month between HK$1.48 and HK$1.71.
How big is Luye Pharma and what is its P/E ratio?
Luye Pharma's market capitalization is HK$6.8B. Its price-to-earnings (P/E) ratio is 24.4: you pay HK$24.4 for each HK$1.00 of yearly earnings.
How volatile is 2186.HK?
ATLAS estimates annual volatility at 42%. In a typical month, half of the outcomes end between HK$1.48 and HK$1.71.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer